Details for New Drug Application (NDA): 021777
✉ Email this page to a colleague
The generic ingredient in AMRIX is cyclobenzaprine hydrochloride. There are sixteen drug master file entries for this compound. Fifty-eight suppliers are listed for this compound. Additional details are available on the cyclobenzaprine hydrochloride profile page.
Summary for 021777
Tradename: | AMRIX |
Applicant: | Teva Pharms Intl |
Ingredient: | cyclobenzaprine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 021777
Physiological Effect | Centrally-mediated Muscle Relaxation |
Suppliers and Packaging for NDA: 021777
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
AMRIX | cyclobenzaprine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021777 | NDA AUTHORIZED GENERIC | Teva Pharmaceuticals USA, Inc. | 0093-1920 | 0093-1920-06 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-1920-06) |
AMRIX | cyclobenzaprine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021777 | NDA AUTHORIZED GENERIC | Teva Pharmaceuticals USA, Inc. | 0093-1921 | 0093-1921-06 | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0093-1921-06) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 15MG | ||||
Approval Date: | Feb 1, 2007 | TE: | AB | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 30MG | ||||
Approval Date: | Feb 1, 2007 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 021777
Complete Access Available with Subscription